You have no items in your shopping cart.
0item(s)
You have no items in your shopping cart.
NAD+ · MOTS-c · Epitalon · GHK-Cu
The Longevity Protocol™ is a research framework built around four compounds frequently examined in scientific literature relating to NAD+-dependent signalling, mitochondrial stress adaptation, telomere biology, and extracellular matrix remodelling. Supplied strictly for in-vitro laboratory investigation.
Longevity research commonly studies interconnected systems: NAD+ as a redox and enzyme substrate (PARPs/sirtuins/salvage pathway), mitochondrial-derived signalling peptides (stress adaptation), telomere/telomerase endpoints (genomic stability models), and extracellular matrix organisation (structural signalling and remodelling).
NAD+ is a foundational coenzyme in redox biology and a substrate for NAD+-consuming enzymes linked to DNA repair signalling and transcriptional regulation. Research frequently examines NAD+ availability through salvage pathway dynamics and NAMPT-linked regulation in experimental systems.
Established cellular biochemistry; research context model-dependent.
MOTS-c is studied as a mitochondrial-encoded peptide associated with metabolic stress signalling and adaptive responses. Literature discusses AMPK-related mechanisms and stress-responsive transcriptional behaviour in controlled experimental models.
Strong preclinical foundation; human translation investigational.
Epitalon is a tetrapeptide explored in experimental systems examining telomerase activity and telomere length endpoints. Current literature includes modern reviews and cell-line studies investigating mechanism-level behaviour under controlled conditions.
Preclinical emphasis; translational interpretation investigational.
GHK-Cu is a naturally occurring copper-binding tripeptide with a long research history in tissue remodelling biology. Research discusses ECM protein signalling and oxidative stress contexts in experimental models, with age-associated decline in endogenous levels frequently noted.
Substantial in-vitro / dermal research; broader contexts model-dependent.
The Longevity Protocol™ is presented for scientific context only. Mechanisms described reflect experimental literature and should not be interpreted as clinical claims. Axiom supplies all compounds strictly for in-vitro laboratory research.
View Research CompoundsCompliance Position
Axiom products are not approved medicines and are not intended for human consumption, medical treatment, or diagnostic use.
Controlled. Considered. Engineered.